Dimethyl Fumarate Ameliorates Doxorubicin-Induced Cardiotoxicity By Activating the Nrf2 Pathway.

Hu, Xiaoliang; Li, Cheng; Wang, Qian; Wei, Zhixing; Chen, Taizhong; Wang, Yuepeng; Li, Yigang

Hu, Xiaoliang; Li, Cheng; Wang, Qian; Wei, Zhixing; Chen, Taizhong; Wang, Yuepeng; Li, Yigang.

Afiliação

Hu X; Department of Cardiology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Li C; Department of Cardiology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang Q; Department of Cardiology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wei Z; Department of Cardiology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen T; Department of Cardiology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang Y; Department of Cardiology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Li Y; Department of Cardiology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Front Pharmacol ; 13: 872057, 2022.

Article em En | MEDLINE | ID: mdl-35559248

Palavras-chave

Nrf2 pathway; apoptosis; dimethyl fumarate; doxorubicin; oxidative stress

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google